The government has announced immediate cuts in the prices of 17 medicines, including those used for cervical cancer and inhalers used by asthmatics.

It said that the price of 146 medicines has been reduced since July 2010 following the intervention of Parliamentary Secretary Chris Said.

The price cuts announced today range from 2% to 27% to reflect price levels on mainland Europe.

The medicines include Cervaris (0.5ml suspension for injection in a pre-filled syringe) which is used to counter cervical cancer. Its price has been reduced by €40.61, or 27%.

The inhaler Seredite Diskus has seen its price reduced by €11.03 or 15%. Flixotide Evohaler  has seen its price  reduced by €2 of 11%.

Tamiflu prices fell by between 12 and 16% according to dose and packet. 

Medicine Packet Old price (€) New price(€) Price reduction (€)
Cervarix 1 x 0.5ml dose for injection - 1 prefilled syringe with 0.5ml suspension and 1 needle 149.45 108.84 -40.61
Evista 60mg film-coated tablets x 28 39.90 35.90 -4.00
Ezetrol™ 10mg tablets x 28 52.06 49.98 -2.08
Flixotide Diskus 100 μg/m.d. inhaler x 60 m.d. 17.60 15.98 -1.62
Flixotide Evohaler 125 μg/m.d. inhaler x 60 m.d. 17.98 15.98 -2.00
Lescol® 40mg capsules x 28 33.23 27.74 -5.49
Mobic® 15mg tablets x 30 23.76 22.00 -1.76
Mobic® 7.5mg tablets x 30 15.54 14.38 -1.16
Seretide Diskus 100 µg/m.d. inhaler x 60 m.d. 41.00 34.80 -6.20
Seretide Diskus 250 µg/m.d. inhaler x 60 m.d. 56.14 49.50 -6.64
Seretide Diskus 500 µg/m.d. inhaler x 60 m.d. 75.82 64.79 -11.03
Seretide Evohaler 25/50 µg/m.d. inhaler 40.80 34.80 -6.00
Tamiflu 30mg capsules x 10 17.90 15.12 -2.78
Tamiflu 45mg capsules x 10 34.35 30.24 -4.11
Tamiflu 75mg capsules x 10 34.25 30.24 -4.01
Xarelto 10mg film-coated tablets x 10 64.48 62.91 -1.57
Xatral® XL 10mg prolonged-release tablets x 30 29.19 25.68 -3.51

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.